Yüklüyor......

Bruising following natalizumab infusion for relapsing-remitting multiple sclerosis: a case report

INTRODUCTION: Natalizumab is a new treatment for relapsing-remitting multiple sclerosis. Because of limited experience of this treatment, medical professionals must be alert to possible side effects. CASE PRESENTATION: We present a 34-year-old Caucasian woman with relapsing-remitting multiple sclero...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Gatzonis, Stylianos, Siatouni, Anna
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2009
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2827173/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4076/1752-1947-3-8955
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!